CN103223151B - 一种增白祛斑的中药组合物及其制剂的制备方法 - Google Patents
一种增白祛斑的中药组合物及其制剂的制备方法 Download PDFInfo
- Publication number
- CN103223151B CN103223151B CN201310161887.8A CN201310161887A CN103223151B CN 103223151 B CN103223151 B CN 103223151B CN 201310161887 A CN201310161887 A CN 201310161887A CN 103223151 B CN103223151 B CN 103223151B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- dispelling
- brightening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000005282 brightening Methods 0.000 title claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 20
- 241000255791 Bombyx Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 12
- 239000009490 scorpio Substances 0.000 claims description 11
- 239000006187 pill Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000011282 treatment Methods 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 7
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 2
- 235000014290 Artemisia anomala Nutrition 0.000 abstract 1
- 241000123844 Artemisia anomala Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001038563 Pseudostellaria Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 238000011284 combination treatment Methods 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 16
- 206010008570 Chloasma Diseases 0.000 description 13
- 208000003351 Melanosis Diseases 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 240000003690 Callicarpa japonica Species 0.000 description 1
- 235000017595 Callicarpa japonica Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000003211 Corylus maxima Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000009428 kamisyoyo san Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000001440 melanophage Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
对比组别 | 治愈 | 好转(例) | 无效(例) | 治愈率 | 有效率 |
治疗组1 | 56 | 38 | 6 | 56% | 94% |
治疗组2 | 59 | 39 | 2 | 59% | 98% |
治疗组3 | 58 | 38 | 4 | 58% | 96% |
对照组 | 45 | 32 | 23 | 45% | 77% |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310161887.8A CN103223151B (zh) | 2013-05-06 | 2013-05-06 | 一种增白祛斑的中药组合物及其制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310161887.8A CN103223151B (zh) | 2013-05-06 | 2013-05-06 | 一种增白祛斑的中药组合物及其制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103223151A CN103223151A (zh) | 2013-07-31 |
CN103223151B true CN103223151B (zh) | 2014-12-17 |
Family
ID=48833947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310161887.8A Expired - Fee Related CN103223151B (zh) | 2013-05-06 | 2013-05-06 | 一种增白祛斑的中药组合物及其制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103223151B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103932953B (zh) * | 2014-05-13 | 2015-09-30 | 王志伟 | 含有人参提取物的美白祛斑化妆品 |
CN108096147A (zh) * | 2018-01-16 | 2018-06-01 | 徐艳芹 | 一种祛斑增白美容养颜的中药面膜的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011460A (zh) * | 2007-02-06 | 2007-08-08 | 朱炜 | 用于祛斑兼具美白效果的药物组合物 |
CN101015585A (zh) * | 2007-02-12 | 2007-08-15 | 朱天娇 | 用于祛斑美白的药物组合物 |
-
2013
- 2013-05-06 CN CN201310161887.8A patent/CN103223151B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011460A (zh) * | 2007-02-06 | 2007-08-08 | 朱炜 | 用于祛斑兼具美白效果的药物组合物 |
CN101015585A (zh) * | 2007-02-12 | 2007-08-15 | 朱天娇 | 用于祛斑美白的药物组合物 |
Non-Patent Citations (1)
Title |
---|
浅谈中药在护肤祛斑与抗衰老方面的研究进展;谢臻等;《亚太传统医药》;20110430;第7卷(第4期);160-162 * |
Also Published As
Publication number | Publication date |
---|---|
CN103223151A (zh) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751570A (zh) | 一种内服治疗偏头痛的中药 | |
CN104667244A (zh) | 一种治疗原发性痛经的足浴组合物 | |
CN104523865A (zh) | 一种治疗乳腺疾病的药物 | |
CN103272199A (zh) | 一种治疗冻伤的药物 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104306540B (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
CN103223151B (zh) | 一种增白祛斑的中药组合物及其制剂的制备方法 | |
CN103330835A (zh) | 一种治疗更年期综合症的中药组合物 | |
CN102920951A (zh) | 一种治疗胃癌的中药 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN101874850A (zh) | 一种治疗慢性荨麻疹的药 | |
CN104547748A (zh) | 一种痤疮药及制备方法 | |
CN101204494B (zh) | 一种治疗慢性肠炎的药物 | |
CN103585609A (zh) | 一种治疗痛经的中药组合物及其制备方法 | |
CN103006997A (zh) | 一种治疗开颅术后头痛的药物 | |
CN101953930A (zh) | 一种治疗头癣的外用中药 | |
CN100411681C (zh) | 缩短坐月子时间及治疗人流后遗症产后风的药物 | |
CN104257813B (zh) | 一种调理气血的中药组合物及其制备方法 | |
CN103463412A (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN104189608B (zh) | 一种治疗复发性口腔溃疡的中药制剂及制备方法 | |
CN103356959B (zh) | 一种治疗乳腺小叶增生的药物组合物 | |
CN112675264B (zh) | 治疗银屑病的组合物、制备方法及其应用 | |
CN102836405B (zh) | 一种治疗脑瘤的药物 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: SUN FENGQING Effective date: 20150106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 265100 YANTAI, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150106 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: The third people's Hospital of Haiyang City, No. 3 265100 Shandong city of Yantai province Haiyang City Hai Hua Lu Patentee before: Sun Fengqing |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200628 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200914 Address after: 065000 unit 203, building 10, garden building, Xinhua community, Guangyang District, Langfang City, Hebei Province (Office Limited) Patentee after: Saijue Biotechnology (Hebei) Co.,Ltd. Address before: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 |
|
CF01 | Termination of patent right due to non-payment of annual fee |